Invivyd (IVVD) Capital Expenditures (2021 - 2025)
Invivyd (IVVD) posted Capital Expenditures of $183000.0 for Q4 2025, up 1930.0% on a QoQ basis from -$10000.0 in Q3 2025, and up 3760.0% year-over-year from $4740.9 in Q4 2024.
Invivyd (IVVD) Capital Expenditures (2021 - 2025) Analysis & Trends
Invivyd's Capital Expenditures history runs 5 years deep, the most recent figure standing at $183000.0 for Q4 2025.
- Quarterly Capital Expenditures rose 3760.0% year-over-year to $183000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $155000.0 (up 10.71% YoY) and the FY2025 annual result came in at $155000.0, up 10.71% from the prior year.
- Capital Expenditures was $183000.0 for Q4 2025 at Invivyd, up from -$10000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $4.8 million in Q4 2022 and bottomed at -$3.1 million in Q1 2022.
- A 5-year average of $330062.5 and a median of -$9000.0 in 2025 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2024 — Capital Expenditures tumbled 1304.81% — and 2025, when it surged 3760.0%.
- Invivyd's Capital Expenditures stood at $3.3 million in 2021, then surged by 44.56% to $4.8 million in 2022, then tumbled by 100.25% to -$12000.0 in 2023, then surged by 58.33% to -$5000.0 in 2024, then jumped by 3760.0% to $183000.0 in 2025.
- Business Quant data shows IVVD's Capital Expenditures at $183000.0 in Q4 2025, -$10000.0 in Q3 2025, and -$8000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 43.25 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 786,000.00 |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn | 183,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 183,000.00 |
| Dec 31, 2025 | 183,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Jun 30, 2025 | -8,000.00 |
| Jun 30, 2025 | -8,000.00 |
| Mar 31, 2025 | -10,000.00 |
| Mar 31, 2025 | -10,000.00 |
| Dec 31, 2024 | -5,000.00 |
| Dec 31, 2024 | -5,000.00 |
| Sep 30, 2024 | -1.46 Mn |
| Sep 30, 2024 | -1.46 Mn |
| Jun 30, 2024 | -76,000.00 |
| Jun 30, 2024 | -76,000.00 |
| Mar 31, 2024 | 1.68 Mn |
| Mar 31, 2024 | 1.68 Mn |
| Dec 31, 2023 | -12,000.00 |
| Dec 31, 2023 | -12,000.00 |
| Sep 30, 2023 | -104,000.00 |
| Sep 30, 2023 | -104,000.00 |